Clinical Trials

40 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, B-Cell

NCT07168291 2025-09-17

Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma

3 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05779930 2025-08-15

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

12 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07068906 2025-07-16

A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

27 enrolled

Lymphoma, B-Cell

NCT04419909 2025-07-02

Retreatment With CTL019/CTL119

12 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, B-Cell

NCT07048353 2025-07-02

CAR-T，MTD

15 enrolled

Lymphoma, Lymphoma, B-Cell

NCT07024147 2025-06-17

JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma

20 enrolled

Phase 1/2 Not yet recruiting

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06767956 2025-06-04

Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy

30 enrolled

Phase 4 Not yet recruiting

Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT06956092 2025-05-02

Glofitamab

40 enrolled

Lymphoma, B-Cell

NCT06894693 2025-03-25

A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies

LymphoidOther hematologic neoplasm

13 enrolled

Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06847529 2025-03-12

Systemic Inflammatory Markers in B-cell Neoplasm

70 enrolled

Lymphoma, B-Cell

NCT06721598 2024-12-06

An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

LymphoidOther hematologic neoplasm

60 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06646666 2024-11-01

ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT

Phase 2 Not yet recruiting

35 enrolled

Lymphoma, B-Cell

NCT06573099 2024-08-27

A Real-World Study on Extranodal Lymphoma

5,000 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT06314828 2024-03-18

A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL

30 enrolled

Lymphoma, B-Cell

NCT06142188 2023-11-21

Relmacabtagene Autoleucel in Hematologic Malignancies

150 enrolled

Lymphoma, Follicular, Lymphoma, B-Cell

NCT05968001 2023-08-01

Obinutuzumab in Chinese Real-world Patients With iNHL

400 enrolled

Lymphoma, B-Cell

NCT05834426 2023-06-22

Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers

50 enrolled

Phase 4 Not yet recruiting

Lymphoma, Non-Hodgkin, Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05814848 2023-06-15

A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma

13 enrolled